Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Endocrinology ; 162(11)2021 11 01.
Article in English | MEDLINE | ID: mdl-34370853

ABSTRACT

Polybrominated diphenyl ethers (PBDEs) have been previously shown to alter various endocrine biosynthetic pathways. Growing epidemiological evidence suggests that PBDEs alter cardiovascular function. The goal of this study was to examine the effects of BDE-47 on adrenal corticosteroid pathways that play vital roles in cardiovascular homeostasis and pathophysiology. The effect of BDE-47 on aldosterone and cortisol secretion was characterized in a human adrenocortical cell line. HAC15 cells were exposed to various concentrations of BDE-47 (1 nM to 100 µM). Cell viability, corticosteroid secretion, gene expression of enzymes involved in corticosteroid synthesis, and metabolic activity was examined. Additionally, Sprague Dawley male rats were orally exposed to BDE-47 (10 or 100 µg/kg), 5 days per week for 16 weeks. Organ weights and plasma corticosteroid levels were measured. In HAC15 cells, basal and stimulated aldosterone and cortisol secretion was significantly increased by BDE-47. Gene expression of several enzymes involved in corticosteroid synthesis and mitochondrial metabolism also increased. In Sprague Dawley rats, adrenal but not heart, kidney, or liver weights, were significantly increased in BDE-47 treatment groups. Plasma corticosterone levels were significantly increased in the 100 µg BDE-47/kg treatment group. No change in plasma aldosterone levels were observed with BDE-47 exposure. These data indicate that BDE-47 disrupts the regulation of corticosteroid secretion and provides further evidence that PBDEs are potential endocrine disruptors. Future studies will determine the underlying molecular mechanism of altered corticosteroid production and examine whether these alterations result in underlying cardiovascular disease in our rodent model of 16-week BDE-47 exposure.


Subject(s)
Adrenal Cortex/drug effects , Halogenated Diphenyl Ethers/pharmacology , Adrenal Cortex/cytology , Adrenal Cortex/metabolism , Adrenal Cortex Hormones/biosynthesis , Animals , Cell Line , Cell Survival/drug effects , Endocrine Disruptors/pharmacology , Humans , Male , Metabolic Networks and Pathways/drug effects , Rats , Rats, Sprague-Dawley
2.
Physiol Rep ; 8(24): e14666, 2021 01.
Article in English | MEDLINE | ID: mdl-33369273

ABSTRACT

The health benefits of the natural polyphenol trans-resveratrol may play an important role in preventing a variety of diseases. Resveratrol has been shown to reduce blood pressure and improve metabolic diseases such as type 2 diabetes mellitus and obesity. Our previous studies examined the role of K+ channels in the vasorelaxation responses to trans-resveratrol in the rat tail artery. During these studies, we uncovered a novel transient contraction prior to the sustained relaxation effect of trans-resveratrol. Thus, the purpose of this study was to determine the role of the endothelium in these vascular contraction and relaxation responses to trans-resveratrol. We additionally sought to determine if the cis-isomer of resveratrol exerts any of the same vascular effects as the trans-isomer. The vascular responses to trans-resveratrol were examined in rat tail arteries with intact or denuded endothelium over a 2-hr period. Additionally, the vascular responses to trans- and cis-resveratrol were compared in rat tail arteries with intact endothelium. Both the transient contractile response and the persistent relaxation response to trans-resveratrol were similar in the arterial rings with intact or denuded endothelium. There was a significant correlation between the initial contraction-enhancing action of trans-resveratrol and the magnitude of the sustained relaxation for vessels with both intact and denuded endothelium. Moreover, we demonstrated that cis-resveratrol produced a significantly greater relaxation response as compared to trans-resveratrol without the initial contractile response. These data demonstrate the role of the vascular smooth muscle in the vascular responses to resveratrol and the potential clinical benefits of the cis-isomer of resveratrol as compared to the trans-isomer.


Subject(s)
Arteries/drug effects , Endothelium, Vascular/drug effects , Muscle Contraction , Resveratrol/pharmacology , Adrenergic Agonists/pharmacology , Animals , Arteries/physiology , Endothelium, Vascular/physiology , Isomerism , Male , Muscle Relaxation , Rats , Rats, Sprague-Dawley , Resveratrol/chemistry , Tail
3.
Mol Cell Endocrinol ; 478: 1-9, 2018 12 15.
Article in English | MEDLINE | ID: mdl-29959979

ABSTRACT

A previous body of work in bovine and rodent models shows that cholinergic agonists modulate the secretion of steroid hormones from the adrenal cortex. In this study we used live-cell Ca2+ imaging to investigate cholinergic activity in the HAC15 human adrenocortical carcinoma cell line. The cholinergic agonists carbachol and acetylcholine triggered heterogeneous Ca2+ oscillations that were strongly inhibited by antagonists with high affinity for the M3 muscarinic receptor subtype, while preferential block of M1 or M2 receptors was less effective. Acute exposure to carbachol and acetylcholine modestly elevated aldosterone secretion in HAC15 cells, and this effect was also diminished by M3 inhibition. HAC15 cells expressed relatively high levels of mRNA for M3 and M2 receptors, while M1 and M5 mRNA were much lower. In conclusion, our data extend previous findings in non-human systems to implicate the M3 receptor as the dominant muscarinic receptor in the human adrenal cortex.


Subject(s)
Adrenal Cortex/cytology , Aldosterone/biosynthesis , Calcium Signaling , Receptor, Muscarinic M3/metabolism , Calcium Signaling/drug effects , Cell Line , Fluorescence , Humans , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptor, Muscarinic M3/antagonists & inhibitors , Receptor, Muscarinic M3/genetics
4.
Physiol Rep ; 6(5)2018 03.
Article in English | MEDLINE | ID: mdl-29504268

ABSTRACT

Vascular reactivity was evaluated in three separate arteries isolated from rats after angiotensin II (Ang II) was infused chronically in two separate experiments, one using a 14-day high, slow-pressor dose known to produce hypertension and the other using a 7-day low, subpressor but hypertensive-sensitizing dose. There were three new findings. First, there was no evidence of altered vascular reactivity in resistance arteries that might otherwise explain the hypertension due to the high Ang II or the hypertensive-sensitizing effect of the low Ang II dose. Second, the high Ang II dose exerted a novel differential effect on arterial contractile responsiveness to the sympathetic neurotransmitter, norepinephrine, depending on the level of sympathetic innervation. It clearly enhanced that responsiveness in the sparsely innervated aorta but not in small mesenteric resistance arteries or the proximal (conductance) portion of the caudal artery, both of which are densely innervated. This suggests that the increased expression of alpha adrenergic receptors after long-term exposure to Ang II as previously reported for aortic smooth muscle, is prevented in densely innervated arteries, likely due to long-term Ang II-mediated increase in sympathetic neural traffic to those vessels. Third, the same high dose of Ang II impaired aortic relaxation in response to the nitric oxide (NO) donor nitroprusside without impairing aortic endothelium-dependent relaxation. NO is the main relaxing substance released by aortic endothelium. Accordingly, it is possible that this dose of Ang II is also associated with enhanced release of and/or enhanced smooth muscle responsiveness to other endothelial relaxing substances in a compensatory capacity.


Subject(s)
Angiotensin II/pharmacology , Arteries/drug effects , Hypertension/etiology , Vasoconstriction , Vasoconstrictor Agents/pharmacology , Vasodilation , Animals , Arteries/physiology , Male , Nitric Oxide/metabolism , Rats , Rats, Sprague-Dawley , Sympathetic Nervous System/physiology
5.
Endocrinology ; 159(1): 238-247, 2018 01 01.
Article in English | MEDLINE | ID: mdl-29088382

ABSTRACT

Hyperaldosteronism is associated with hypertension, cardiac hypertrophy, and congestive heart failure. Steroidogenic factors facilitate aldosterone secretion by increasing adrenal blood flow. Angiotensin (Ang) II decreases adrenal vascular tone through release of zona glomerulosa (ZG) cell-derived vasodilatory eicosanoids. However, ZG cell-mediated relaxation of bovine adrenal cortical arteries to Ang II is not altered by angiotensin type 1 or 2 receptor antagonists. Because traditional Ang II receptors do not mediate these vasorelaxations to Ang II, we investigated the role of Ang II metabolites. Ang III was identified by liquid chromatography-mass spectrometry as the primary ZG cell metabolite of Ang II. Ang III stimulated ZG cell-mediated relaxation of adrenal arteries with greater potency than did Ang II. Furthermore, ZG cell-mediated relaxations of adrenal arteries by Ang II were attenuated by aminopeptidase inhibition, and Ang III-stimulated relaxations persisted. Ang IV had little effect compared with Ang II. Moreover, ZG cell-mediated relaxations of adrenal arteries by Ang II were attenuated by an Ang III antagonist but not by an Ang (1-7) antagonist. In contrast, Ang II and Ang III were equipotent in stimulating aldosterone secretion from ZG cells and were unaffected by aminopeptidase inhibition. Additionally, aspartyl and leucyl aminopeptidases, which convert Ang II to Ang III, are the primary peptidase expressed in ZG cells. This was confirmed by enzyme activity. These data indicate that intra-adrenal metabolism of Ang II to Ang III is required for ZG cell-mediated relaxations of adrenal arteries but not aldosterone secretion. These studies have defined an important role of Ang III in the adrenal gland.


Subject(s)
Adrenal Cortex/blood supply , Angiotensin III/metabolism , Angiotensin II/metabolism , Arterioles/metabolism , Endothelium, Vascular/metabolism , Muscle, Smooth, Vascular/metabolism , Zona Glomerulosa/metabolism , Abattoirs , Adrenal Cortex/drug effects , Adrenal Cortex/metabolism , Aldosterone/metabolism , Aminopeptidases/antagonists & inhibitors , Aminopeptidases/genetics , Aminopeptidases/metabolism , Angiotensin I/antagonists & inhibitors , Angiotensin I/metabolism , Angiotensin II/analogs & derivatives , Angiotensin II/chemistry , Angiotensin II/pharmacology , Animals , Arterioles/cytology , Arterioles/drug effects , Cattle , Cells, Cultured , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Gene Expression Regulation, Enzymologic/drug effects , In Vitro Techniques , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/metabolism , Peptide Fragments/pharmacology , Protease Inhibitors/pharmacology , Vasodilation/drug effects , Zona Glomerulosa/cytology , Zona Glomerulosa/drug effects
6.
Endocrinology ; 155(1): 127-32, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24169551

ABSTRACT

Adrenal blood flow (ABF) is closely coupled to steroid hormone release. ACTH and angiotensin (Ang) II stimulate cortisol and aldosterone secretion; however, their effects on ABF remain poorly defined. We used the laser-Doppler technique to measure rat ABF. Anesthetized male Sprague-Dawley rats were cannulated for mean arterial pressure (MAP) measurement and drug infusion. The left adrenal gland was exposed for ABF measurement. ABF and MAP changes to ACTH and Ang II were determined. Bolus injections of Ang II (0.01-1000 ng/kg) increased ABF (maximal increase = 110 ± 18 perfusion units at 1000 ng/kg) and increased MAP at doses greater than 10 ng/kg (basal, 99.2 ± 1.4 mm Hg; 1000 ng/kg Ang II, 149.7 ± 3.9 mm Hg). ACTH (0.1-1000 ng/kg) increased ABF (maximum increase = 158 ± 33 perfusion units) without increasing MAP. ABF increases induced by Ang II and ACTH were ablated by the cytochrome 450 inhibitor miconazole (2 mg/kg). Bolus injections of endothelin-1 (1-1000 ng/kg) increased ABF only at 1 ng/kg and increased MAP at 1000 ng/kg. Bolus injections of sodium nitroprusside increased ABF at 1 and 10 µg/kg and decreased MAP at 10 µg/kg. Thus, laser-Doppler flowmetry is a useful tool for understanding ABF regulation by peptides that stimulate steroid hormone release. Our results demonstrate that Ang II and ACTH increases in ABF are mediated by a cytochrome P450 metabolite.


Subject(s)
Adrenal Glands/blood supply , Adrenal Glands/drug effects , Aldosterone/metabolism , Adrenal Glands/metabolism , Adrenocorticotropic Hormone/chemistry , Angiotensin II/chemistry , Animals , Arterial Pressure/drug effects , Endothelin-1/metabolism , Laser-Doppler Flowmetry , Male , Nitroprusside/chemistry , Rats , Rats, Sprague-Dawley , Steroids/chemistry , Vasoconstrictor Agents/chemistry
7.
Endocrinology ; 154(12): 4768-76, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24092640

ABSTRACT

Hyperaldosteronism is linked to the development and progression of several different cardiovascular diseases. Angiotensin (Ang) II increases aldosterone secretion and adrenal blood flow. Ang II peptide fragments are produced by various peptidases, and these Angs have diverse and vital physiologic roles. Due to the uncharacteristic vasorelaxation of adrenal arteries by Ang II, we tested the hypothesis that Ang II metabolism contributes to its relaxant activity in adrenal arteries. Metabolism of Angs by bovine adrenal cortical arteries and isolated bovine adrenal vascular cells was measured by liquid chromatography-mass spectrometry. The primary Ang metabolites of adrenal arteries are Ang III and Ang (1-7), with Ang IV produced to a lesser extent. Bovine microvascular endothelial cells produced a similar metabolic profile to adrenal arteries, whereas bovine adrenal artery smooth muscle cells exhibited less metabolism. In preconstricted adrenal arteries, Ang II caused relaxation in picomolar concentrations and constrictions at 10nM. Ang-converting enzyme 2 inhibition augmented this relaxation response, whereas aminopeptidase inhibition did not. Ang III was equipotent to Ang II in relaxing adrenal arteries. Ang IV did not cause relaxation. Nitric oxide synthase inhibition enhanced Ang II-induced constriction of adrenal arteries. Aminopeptidase inhibition increased the concentration range for Ang II-induced constriction of adrenal arteries. Ang III and Ang IV did not change the basal tone but caused constriction of adrenal arteries with nitric oxide synthase inhibition. These data indicate that Ang II metabolism modulates the vascular effects of Ang II in the adrenal vasculature.


Subject(s)
Adrenal Glands/blood supply , Angiotensin III/metabolism , Angiotensin II/metabolism , Angiotensin I/metabolism , Endothelium, Vascular/metabolism , Peptide Fragments/metabolism , Vasodilation/physiology , Adrenal Glands/metabolism , Angiotensin III/genetics , Animals , Cattle , Cells, Cultured , Endothelial Cells/metabolism , Gene Expression Regulation/physiology
8.
Endocrinology ; 154(1): 214-21, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23221601

ABSTRACT

Aldosterone is synthesized in the zona glomerulosa of the adrenal cortex under primary regulation by the renin-angiotensin system. Angiotensin II (A-II) acts through the angiotensin types 1 and 2 receptors (AT1R and AT2R). A-II is metabolized in different tissues by various enzymes to generate two heptapeptides A-III and angiotensin 1-7, which can then be catabolized into smaller peptides. A-II was more potent than A-III in stimulating aldosterone secretion in the adrenocortical cell line HAC15, and A-II, but not A-III, stimulated cortisol secretion. A-II stimulated mRNA expression of steroidogenic acute regulatory protein, 3ß-hydroxysteroid dehydrogenase, CYP11B1, and CYP11B2, whereas A-III stimulated 3ß-hydroxysteroid dehydrogenase, CYP11B1, and CYP11B2 but decreased the expression of CYP17A1 required for cortisol synthesis. The stimulation of aldosterone secretion by A-II and A-III was blocked by the AT1R receptor blocker, losartan, but not by an AT2R blocker. A-II was rapidly metabolized by the HAC15 cells to mainly to angiotensin 1-7, but not to A-III, and disappeared from the supernatant within 6 h. A-III was metabolized rapidly and disappeared within 1 h. In conclusion, A-II was not converted to A-III in the HAC15 cell and is the more potent stimulator of aldosterone secretion and cortisol of the two. A-III stimulated aldosterone secretion but not cortisol secretion.


Subject(s)
Angiotensin III/metabolism , Angiotensin III/pharmacology , Angiotensin II/metabolism , Angiotensin II/pharmacology , 3-Hydroxysteroid Dehydrogenases/genetics , Adrenal Cortex/drug effects , Adrenal Cortex/metabolism , Aldosterone/metabolism , Angiotensin II Type 1 Receptor Blockers/pharmacology , Cell Line , Cytochrome P-450 CYP11B2/genetics , Humans , Hydrocortisone/metabolism , Losartan/pharmacology , Steroid 11-beta-Hydroxylase/genetics , Steroid 17-alpha-Hydroxylase/genetics
9.
Hypertension ; 57(2): 323-9, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21199991

ABSTRACT

Elevated concentrations of aldosterone are associated with several cardiovascular diseases. Angiotensin II (Ang II) increases aldosterone secretion and adrenal blood flow. This concurrent increase in steroidogenesis and adrenal blood flow is not understood. We investigated the role of zona glomerulosa (ZG) cells in the regulation of vascular tone of bovine adrenal cortical arteries by Ang II. ZG cells enhanced endothelium-dependent relaxations to Ang II. The ZG cell-dependent relaxations to Ang II were unchanged by removing the endothelium-dependent response to Ang II. These ZG cell-mediated relaxations were ablated by cytochrome P450 inhibition, epoxyeicosatrienoic acid (EET) antagonism, and potassium channel blockade. Analysis of ZG cell EET production by liquid chromatography/mass spectrometry demonstrated an increase in EETs and dihydroxyeicosatrienoic acids with Ang II stimulation. These EETs and dihydroxyeicosatrienoic acids produced similar concentration-dependent relaxations of adrenal arteries, which were attenuated by EET antagonism. Whole-cell potassium currents of adrenal artery smooth muscle cells were increased by Ang II stimulation in the presence of ZG cells but decreased in the absence of ZG cells. This increase in potassium current was abolished by iberiotoxin. Similarly, 14,15-EET induced concentration-dependent increases in potassium current, which was abolished by iberiotoxin. ZG cell aldosterone release was not directly altered by EETs. These data suggest that Ang II stimulates ZG cells to release EETs and dihydroxyeicosatrienoic acids, resulting in potassium channel activation and relaxation of adrenal arteries. This provides a mechanism by which Ang II concurrently increases adrenal blood flow and steroidogenesis.


Subject(s)
8,11,14-Eicosatrienoic Acid/analogs & derivatives , Angiotensin II/pharmacology , Arteries/drug effects , 8,11,14-Eicosatrienoic Acid/metabolism , 8,11,14-Eicosatrienoic Acid/pharmacology , Adrenal Glands/blood supply , Aldosterone/metabolism , Animals , Arachidonic Acid/metabolism , Arteries/physiology , Cattle , Cells, Cultured , Dose-Response Relationship, Drug , Epoxide Hydrolases/metabolism , In Vitro Techniques , Membrane Potentials/drug effects , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiology , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/physiology , Patch-Clamp Techniques , Potassium Channels/physiology , Vasoconstrictor Agents/pharmacology , Vasodilation/drug effects , Vasodilator Agents/metabolism , Vasodilator Agents/pharmacology , Zona Glomerulosa/cytology , Zona Glomerulosa/drug effects , Zona Glomerulosa/metabolism
10.
Toxicol Sci ; 117(2): 537-46, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20634294

ABSTRACT

National Health and Nutrition Examination Survey data show an association between hypertension and exposure to dioxin-like halogenated aromatic hydrocarbons (HAHs). Furthermore, chronic exposure of mice to the prototypical HAH, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), induces reactive oxygen species (ROS), endothelial dysfunction, and hypertension. Because TCDD induces cytochrome P4501A1 (CYP1A1) and CYP1A1 can increase ROS, we tested the hypothesis that TCDD-induced endothelial dysfunction and hypertension are mediated by CYP1A1. CYP1A1 wild-type (WT) and knockout (KO) mice were fed one control or TCDD-containing pill (180 ng TCDD/kg, 5 days/week) for 35 days (n = 10-14/genotype/treatment). Blood pressure was monitored by radiotelemetry, and liver TCDD concentration, CYP1A1 induction, ROS, and aortic reactivity were measured at 35 days. TCDD accumulated to similar levels in livers of both genotypes. TCDD induced CYP1A1 in endothelium of aorta and mesentery without detectable expression in the vessel wall. TCDD also induced superoxide anion production, measured by NADPH-dependent lucigenin luminescence, in aorta, heart, and kidney of CYP1A1 WT mice but not KO mice. In contrast, TCDD induced hydrogen peroxide, measured by amplex red assay, to similar levels in aorta of CYP1A1 WT and KO mice but not in heart or kidney. TCDD reduced acetylcholine-dependent vasorelaxation in aortic rings of CYP1A1 WT mice but not in KO mice. Finally, TCDD steadily increased blood pressure after 15 days, which plateaued after 25 days (+20 mmHg) in CYP1A1 WT mice but failed to alter blood pressure in KO mice. These results demonstrate that CYP1A1 is required for TCDD-induced cardiovascular superoxide anion production, endothelial dysfunction, and hypertension.


Subject(s)
Cytochrome P-450 CYP1A1/biosynthesis , Environmental Pollutants/toxicity , Hypertension/chemically induced , Polychlorinated Dibenzodioxins/toxicity , Vasodilation/drug effects , Animals , Aorta/drug effects , Aorta/enzymology , Blood Pressure/drug effects , Cytochrome P-450 CYP1A1/genetics , Disease Models, Animal , Drug Synergism , Endothelium, Vascular/drug effects , Endothelium, Vascular/enzymology , Environmental Pollutants/pharmacokinetics , Enzyme Induction/drug effects , Gene Expression Regulation, Enzymologic/drug effects , Hypertension/enzymology , Liver/drug effects , Liver/metabolism , Male , Mesenteric Arteries/drug effects , Mesenteric Arteries/enzymology , Mice , Mice, Inbred C57BL , Mice, Knockout , Oxidative Stress/drug effects , Polychlorinated Dibenzodioxins/pharmacokinetics , Reactive Oxygen Species/metabolism , Vasodilation/physiology
11.
Hypertension ; 55(2): 547-54, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20038752

ABSTRACT

Adrenic acid (docosatetraenoic acid), an abundant fatty acid in the adrenal gland, is identical to arachidonic acid except for 2 additional carbons on the carboxyl end. Adrenic acid is metabolized by cyclooxygenases, cytochrome P450s, and lipoxygenases; however, little is known regarding the role of adrenic acid and its metabolites in vascular tone. Because of its abundance in the adrenal gland, we investigated the role of adrenic acid in vascular tone of bovine adrenal cortical arteries and its metabolism by bovine adrenal zona glomerulosa cells. In adrenal cortical arteries, adrenic acid caused concentration-dependent relaxations, which were inhibited by the epoxyeicosatrienoic acid antagonist 14,15-epoxyeicosa-5(Z)-enoic acid and the cytochrome P450 inhibitor SKF-525A. The large-conductance calcium-activated potassium channel blocker iberiotoxin or removal of the endothelium abolished these relaxations. Reverse-phase high-pressure liquid chromatography and liquid chromatography/mass spectrometry isolated and identified numerous adrenic acid metabolites from zona glomerulosa cells, including dihomo-epoxyeicosatrienoic acids and dihomo-prostaglandins. In denuded adrenal cortical arteries, adrenic acid caused concentration-dependent relaxations in the presence of zona glomerulosa cells but not in their absence. These relaxations were inhibited by SKF-525A, 14,15-epoxyeicosa-5(Z)-enoic acid, and iberiotoxin. Dihomo-16,17-epoxyeicosatrienoic acid caused concentration-dependent relaxations of adrenal cortical arteries, which were inhibited by 14,15-epoxyeicosa-5(Z)-enoic acid and high potassium. Our results suggest that adrenic acid relaxations of bovine adrenal cortical arteries are mediated by endothelial and zona glomerulosa cell cytochrome P450 metabolites. Thus, adrenic acid metabolites could function as endogenous endothelium-derived and zona glomerulosa-derived hyperpolarizing factors in the adrenal cortex and contribute to the regulation of adrenal blood flow.


Subject(s)
Adrenal Glands/metabolism , Erucic Acids/metabolism , Erucic Acids/pharmacology , Proadifen/pharmacology , Adrenal Glands/blood supply , Analysis of Variance , Animals , Biological Factors/metabolism , Cattle , Cells, Cultured , Chromatography, High Pressure Liquid , Cytochrome P-450 Enzyme System/metabolism , Endothelium, Vascular/metabolism , Fatty Acids, Unsaturated , Potassium Channels, Calcium-Activated/pharmacology , Probability , Vascular Resistance/drug effects , Vascular Resistance/physiology , Vasodilation/drug effects , Vasodilation/physiology , Zona Glomerulosa/blood supply , Zona Glomerulosa/metabolism
12.
Article in English | MEDLINE | ID: mdl-19953399

ABSTRACT

The developing cardiovascular system is a sensitive target of many environmental pollutants, including dioxins, dioxin-like polychlorinated biphenyls (PCBs), and some pesticides such as methyl parathion. Laboratory research has utilized a variety of vertebrate models to elucidate potential mechanisms that mediate this cardioteratogenicity and to establish the sensitivity of different species for predicting potential risk to environmental and human health. Studies of dioxin and dioxin-like PCBs have illustrated that piscine, avian, and mammalian embryos exhibit cardiovascular structural changes and functional deficits, although the specific characteristics vary among the individual models. Piscine models typically exhibit reduced blood flow, altered heart looping, and reduced heart size and contraction rate. The chick embryo exhibits extensive cardiac dilation, thinner ventricle walls, and reduced responsiveness to chronotropic stimuli, while the murine embryo exhibits reduced heart size. It is notable that in all models the dioxin-associated cardioteratogenicity is associated with increases in cardiovascular apoptosis and decreases in cardiocyte proliferation. While the cardiotertogenicity in piscine and avian species is associated with overt morbidity and mortality, that is not the case for the murine embryo. However, murine offspring exposed during development to dioxin exhibit cardiac hypertrophy and an increased sensitivity to a second cardiovascular insult in adulthood. Thus, although the mammalian embryo is less sensitive to cardiovascular defects by dioxin and dioxin-like compounds, developmental exposure increases the risk of cardiovascular disease later in life. The impact of developmental exposure to dioxin-like chemicals on human cardiovascular disease susceptibility is not known. However, recent animal research has confirmed human epidemiology studies that dioxin exposure in adulthood is associated with hypertension and cardiovascular disease.


Subject(s)
Dioxins/toxicity , Heart Defects, Congenital/chemically induced , Pesticides/toxicity , Polychlorinated Biphenyls/toxicity , Animals , Birds/abnormalities , Fishes/abnormalities , Heart/drug effects , Heart/physiopathology , Humans , Mice , Models, Animal , Myocardium/ultrastructure
13.
Cardiovasc Toxicol ; 8(4): 181-93, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18850075

ABSTRACT

The mechanisms by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increases the incidence of human cardiovascular disease are not known. We investigated the degree to which cardiovascular disease develops in mice following subchronic TCDD exposure. Adult male C57BL/6 mice were dosed with vehicle or 300 ng TCDD/kg by oral gavage three times per week for 60 days. Blood pressure was recorded by radiotelemetry and aortic endothelial function was assessed by acetylcholine-induced vasorelaxation. Mean arterial pressure of TCDD-exposed mice was increased significantly by day 4 and between days 7-10, 25-35, and 45-60 with two periods of normalization on days 11-24 and days 36-39. Consistent with a prolonged period of systemic hypertension, heart weight was increased and was associated with concentric left ventricular hypertrophy. Significant increases in superoxide production also were observed in the kidney, heart, and aorta of TCDD-exposed mice. Furthermore, increased aortic superoxide resulted in endothelial dysfunction as demonstrated by significant impairment of acetylcholine-induced vasorelaxation in TCDD-exposed mice, which was restored by tempol, a superoxide dismutase (SOD) mimetic. Our model is the first to definitely demonstrate that sustained AhR activation by TCDD increases blood pressure and induces cardiac hypertrophy, which may be mediated, in part, by increased superoxide.


Subject(s)
Cardiomegaly/metabolism , Environmental Pollutants/toxicity , Hypertension/metabolism , Polychlorinated Dibenzodioxins/toxicity , Superoxides/metabolism , Vasodilation/physiology , Acetylcholine/pharmacology , Administration, Oral , Animals , Aorta/drug effects , Aorta/metabolism , Blood Pressure/drug effects , Blood Pressure/physiology , Cardiomegaly/chemically induced , Cardiomegaly/pathology , Disease Models, Animal , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Gene Expression/drug effects , Heart/drug effects , Heart Ventricles/chemistry , Heart Ventricles/drug effects , Heart Ventricles/metabolism , Heart Ventricles/pathology , Hypertension/chemically induced , Hypertension/pathology , Kidney/drug effects , Kidney/metabolism , Male , Mice , Mice, Inbred C57BL , Myocardium/metabolism , Myocardium/pathology , Organ Size/drug effects , Reactive Oxygen Species/metabolism , Receptors, Aryl Hydrocarbon/genetics , Receptors, Aryl Hydrocarbon/metabolism , Vasodilation/drug effects
14.
Toxicol Sci ; 101(2): 321-30, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17975115

ABSTRACT

The mouse heart is a target of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) during fetal development, and microarray analysis demonstrates significant changes in expression of cardiac genes involved in extracellular matrix (ECM) remodeling. We tested the hypothesis that developmental TCDD exposure would disrupt cardiac ECM expression and be associated with changes in cardiac morphology in adulthood. In one study, time-pregnant C57BL/6 mice were dosed with corn oil or 1.5, 3.0, or 6.0 microg TCDD/kg on gestation day (GD) 14.5 and sacrificed on GD 17.5, when changes in fetal cardiac mRNA expression were analyzed using quantitative PCR. TCDD induced mRNA expression of genes associated with ECM remodeling (matrix metalloproteinase 9 and 13, preproendothelin-1 [preproET-1]), cardiac hypertrophy (atrial natriuretic peptide, beta-myosin heavy chain, osteopontin), and aryl hydrocarbon receptor (AHR) activation (cytochrome P4501A1, AHR repressor). Further, all TCDD-induced changes required the AHR since gene expression was not altered in AHR knockout fetuses. In a second study, time-pregnant mice were treated with corn oil or 6.0 microg TCDD/kg on GD 14.5, and male offspring were assessed for changes in cardiac gene expression and cardiac and renal morphology at 3 months. All TCDD-induced changes in cardiac gene expression observed fetally, except for preproET-1, remained induced in the hearts of adult male offspring. Adult male offspring of TCDD-exposed dams also displayed cardiac hypertrophy, decreased plasma volume, and mild hydronephrosis. These results demonstrate that in utero and lactational TCDD exposures alter cardiac gene expression and cardiac and renal morphology in adulthood, which may increase the susceptibility to cardiovascular dysfunction.


Subject(s)
Aging/genetics , Environmental Pollutants/toxicity , Fetal Heart/drug effects , Gene Expression/drug effects , Kidney/drug effects , Myocardium , Polychlorinated Dibenzodioxins/toxicity , Prenatal Exposure Delayed Effects/chemically induced , Animals , Female , Fetal Heart/metabolism , Fetal Heart/pathology , Gene Expression Regulation, Developmental/drug effects , Gestational Age , Kidney/embryology , Kidney/growth & development , Kidney/metabolism , Kidney/pathology , Lactation , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Myocardium/metabolism , Myocardium/pathology , Pregnancy , Prenatal Exposure Delayed Effects/genetics , Receptors, Aryl Hydrocarbon/genetics , Receptors, Aryl Hydrocarbon/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...